Annual Research Seminar, March 9-10, 2017

The annual research seminar of Oslo Diabetes Research Centre gathered researchers from ten different research groups at Thorbjørnrud, March 9-10, 2017. Our researchers assembled to share their experiences in two days of lectures. Ongoing projects, unpublished data and research in progress were discussed. We were also delighted to welcome the invited speakers: Marcel den Hoed, Assistant professor at Uppsala University,  and Bjørn Olav Åsvold, Associate professor at NTNU .

Read More »

NOK 13 Million in total research grants from Regional Health Authority

Five projects from Oslo Diabetes Research Centre were granted support as the board of the South-Eastern Norway Regional Health Authority (Helse Sør-Øst) distributed financial resources to new research projects for 2017:

 “Atherosclerosis and Childhood Diabetes” – a doctoral project for three years lead by Hanna Dis Margeirsdottir, postdoctoral fellow.

Thyroid and Virus Detection and Intervention” – a doctoral project for three years lead by Professor Knut Dahl-Jørgensen.

Are epigenetic modifications of key genes in placenta important links between mother’s lifestyle and fetal pre and postnatal growth patterns and future diabetes risk?” – research grant for four years for Line Sletner, postdoctoral fellow.

Early nutrition and risk of islet autoimmunity and type 1 diabetes” – a post-doctoral project for three years lead by Professor Geir Joner.

Nutritional environment of the unborn child: The role of the placenta in the maternalfetal interaction” – research grant for three months for Trond Michelsen, postdoctoral fellow.

Cover picture and article in Diabetologia

coverfotoCover picture in October issue of the journal Diabetologia from the published article “LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro” Collaboration study between members form the two groups (Birkeland and Jenssen) at Oslo Diabetes Research Center.

Bente Halvorsen et al. found increased plasma LIGHT levels in two cohorts of type 2 diabetes patients (Italian and Norwegian). By using in vitro approach with human islets and endothelial cells they also showed that LIGHT could be part of a pathogenic loop, promoting the progression of type 2 diabetes mellitus by impairing insulin secretion by islet cells and contributing to vascular inflammation. Read More »